Phreesia Inc. (NYSE: PHR) is a healthcare technology company that provides patient intake management solutions. The company aims to streamline the patient intake process for healthcare providers, enhancing efficiency and patient experience. Phreesia operates in a competitive landscape with other healthcare technology firms, striving to innovate and improve its offerings continuously.
On December 8, 2025, Phreesia reported earnings per share (EPS) of $0.07, which was below the estimated $0.24. This shortfall in EPS indicates that the company's profitability did not meet market expectations. Despite this, CEO Chaim Indig expressed pride in the company's execution, highlighting revenue and profit outcomes, as well as product updates and client stories.
Phreesia generated revenue of approximately $120.3 million, missing the estimated $132.5 million. This revenue miss suggests that the company faced challenges in achieving its sales targets. Analysts had anticipated earnings of 2 cents per share on revenue of $120.05 million, indicating that the actual revenue was slightly above these expectations, but still below the broader market estimates.
The company's financial ratios provide further insight into its performance. The price-to-sales ratio of about 2.60 suggests that investors are willing to pay $2.60 for every dollar of sales. The enterprise value to sales ratio is approximately 2.38, indicating the company's valuation relative to its revenue.
Phreesia's financial health is also highlighted by its low debt-to-equity ratio of about 0.01, suggesting minimal reliance on debt financing. The current ratio of approximately 2.44 indicates a strong ability to cover short-term liabilities with short-term assets. The company maintains a solid liquidity position, which is crucial for its ongoing operations and future growth.
